Risk appetite

The first two categories concern the entity itself, while the latter two concern the entity s relations with its external environment. In all cases, risk is framed as something that has to be managed to ensure that risks remain within the entity s risk appetite and to provide reasonable assurance that entity objectives can be achieved. 

The amount of risk a company or organization is willing to accept before initiating any action to address (and mitigate) the risk is referred to as risk appetite. 

The key risk indicator (KRl) is an early warning to indicate that risk appetite is reached. So, this is an early warning for a potential risk, and is important in risk... 

Tailored Risk management shall be tailor-made to suit the external and internal context discussed earlier (see Table VI/TO-l), and should corroborate with the company risk profile and risk appetite (see Chapter I), that is, risk management shall be tailored to the environment. 

Part of the risk acceptance process is a methodical decision-making approach. If the risks are not acceptable, then the system must be modified and the hazard identification process must be followed once again. If the risks are acceptable, then good documentation with written rationale is imperative to protect against liability claims. Chapters 13 and 14 address these issues in depth. Some people will use the term risk appetite to describe this process. The very first step—define objectives— should clearly define what is an acceptable risk (risk tolerance or risk appetite) that the company is willing to accept. 

Reduction in dietary protein intake has been shown to slow the progression of kidney disease.8 However, protein restriction must be balanced with the risk of malnutrition in patients with CKD. Patients with a GFR less than 25 mL/minute/ 1.73 m2 received the most benefit from protein restriction 8 therefore, patients with a GFR above this level should not restrict protein intake. The NKF recommends that patients who have a GFR less than 25 mL/minute/1.73 m2 who are not receiving dialysis, however, should restrict protein intake to 0.6 g/kg per day. If patients are not able to maintain adequate dietary energy intake, protein intake maybe increased up to 0.75 g/kg per day.15 Malnutrition is common in patients with ESRD for various reasons, including decreased appetite, hypercatabolism, and nutrient losses through dialysis. For this reason, patients receiving dialysis should maintain protein intake of 1.2 g/kg per day to 1.3 g/kg per day. 

Bupropion causes insomnia, nightmares, decreased appetite, anxiety, and tremors, but the most concerning adverse effect is seizures. Because of the risk for seizures, patients who should not receive the drug include those with a CNS lesion or those with a history of seizures, head trauma, or bulimia. The daily dose of bupropion should not exceed 450 mg/day, and any single dose of the immediate-release formulation should not exceed 150 mg/day Occurrences of insomnia and/or nightmares often respond to moving the last daily dose from bedtime to late afternoon.7,9,22,23... 

Wansink, B. andWestgren, R.E. 2004. Profiling taste-motivated segments. Appetite 41, 323-327. Wildavsky, A. and Dake, K. 1990. Theories of risk perception Who fears what and why Daedalus 119, 41-60. 

Other effects caused by methamphetamine include headaches, decreased appetite, dry mouth, dilated pupils, trembling, chest pains, increased respiration and shortness of breath, hyperthermia (elevated body temperature), insomnia, and nausea and vomiting. In more severe cases (i.e., overdoses) it can produce seizures and convulsions, stroke, heart attacks, and death. The risk of encountering these more serious side effects are greatly increased when methamphetamine is used in combination with other drugs like cocaine, marijuana, alcohol, and heroin. 

The most common side effects of bupropion are decreased appetite and abdominal discomfort. But more serious is the risk of seizure when high doses are taken. For this reason, patients with epilepsy should not take bupropion. 

---